Autoimmune liver disease, Including autoimmune hepatitis (AIH), primary biliary cholangitis, primary biliary cholangitis, PBC), primary sclerosing cholangitis (PSC) and IgG4-related sclerosing cholangitis (IgG4-SC).
Conditions
Interventions
Sponsors
Tongji Hospital of Tongji University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1.Meeting the AIH simplified diagnostic score criteria proposed by the International Autoimmune Hepatitis Group (IAIHG) in 2008; 2.Meeting the diagnostic criteria for primary biliary cholangitis; 3.Meeting the diagnostic criteria for primary sclerosing cholangitis; 4.Meeting the lgG4-SC clinical diagnostic criteria; 5.Age >18, <=75 years old.
Exclusion criteria
Exclusion criteria: 1.Patients with viral, drug-induced, alcoholic, fatty liver injury and hepatic decompensation; 2.Patients with severe diabetes, heart, lung, kidney and other organ diseases or functional impairment; 3.Those who have no relevant follow-up information and cannot be contacted.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TBIL;ALT;AST;lgG;Adverse effects; | — |
Secondary
| Measure | Time frame |
|---|---|
| ALP;Complication; | — |
Countries
China
Contacts
Public ContactWeifeng Tan
Tongji Hospital of Tongji University
Outcome results
None listed